Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

182.17
Delayed Data
As of Sep 24
 +2.09 / +1.16%
Today’s Change
136.50
Today|||52-Week Range
186.44
+21.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Quarter 2
2018
Revenue and IncomeNet Revenues578.2M651.6M640.8M754.8M
 
 
 
 
 
Cost of Goods Sold57.6M67.6M55.3M86.3M
 
 
 
 
 
Depreciation And Amortization15.2M16.4M16.3M18.1M
 
 
 
 
 
 
Operating ExpensesGross Income505.3M567.6M569.2M650.5M
 
 
 
 
 
General Expenses570.6M441.5M440.4M474.8M
 
 
 
 
 
Research And Development454.9M306.7M310.6M337.5M
 
 
 
 
 
Total Operating Expenses643.4M525.5M512.0M579.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-65.3M126.1M128.8M175.6M
 
 
 
 
 
Extraordinary Credit0.000.0076.0K--
 
 
Extraordinary Charge-264.9M-1.5M-1.5M-4.2M
 
 
 
 
 
Interest Expense On Debt13.6M12.5M11.1M10.1M
 
 
 
 
 
Other Expenses-73.5M352.0K98.3M55.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-417.2M112.4M214.6M216.6M
 
 
 
 
 
Income Taxes-125.9M-10.3M-12.7M-10.3M
 
 
 
 
 
Minority Interest-188.3M-1.5M-17.0M-1.1M
 
 
 
 
 
Net Income-103.0M100.6M210.2M207.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS250.3M251.6M253.2M254.1M
 
 
 
 
 
Shares To Calculate EPS Diluted250.3M256.8M258.5M258.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.41$0.39$0.81$0.80
 
 
 
 
 
EPS Diluted-$0.41$0.39$0.81$0.80